The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reissue: Rule 2.8 - Mouchel Rejection

29 Mar 2011 10:37

The Company referred to in the body of the `Rule 2.8 - Mouchel Rejection' announcement released today, 29 March 2011, at 0910 under PRN ref PRNUK-2903110907-37B4 should be linked to Mouchel Group plc

The announcement text is unchanged and is reproduced in full below.

Interserve Plc29 March 2011

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO ANY

JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS

OF SUCH JURISDICTION. Interserve Plc - No intention to make an offer following rejection of a Revised Proposal

Further to the announcement made by Mouchel Group plc ("Mouchel") on 29 March 2011, Interserve Plc ("Interserve" or the "Company") confirms that Interserve has no intention to make an offer for Mouchel.

On 25 February 2011, Interserve confirmed that it had entered into a co-operation agreement with Mouchel on the 24 February 2011 which provided Interserve "preferred possible offeror" status following the submission of an indicative proposal, the terms of which the Board of Mouchel was willing to recommend to its shareholders.

Following detailed due diligence, Interserve modified its initial proposal and submitted a revised proposal to the Board of Mouchel valuing each issued Mouchel share at 135 pence including 50 pence in cash. This proposal, which Interserve believes to be in the best interests of both sets of shareholders, was, disappointingly, rejected on 29 March 2011.

For the purposes of the Takeover Code, Interserve reserves the right to make or participate in an offer for Mouchel (and / or take any other action which would otherwise be restricted under Rule 2.8 of the Takeover Code) within the six months following the date of this announcement:

i. with the agreement or recommendation of the Board of Mouchel;

ii. following the announcement of an offer by or on behalf of a third party for

Mouchel;

iii. following the announcement by Mouchel of a "whitewash" proposal or a

reverse takeover; or

iv. if there is a material change of circumstances.

Commenting on the announcement Chief Executive of Interserve, Adrian Ringrose, said

"Following several weeks of due diligence we put a revised proposal to the Mouchel Board that we believe was in the interests of both Interserve and Mouchel shareholders. Following Mouchel's decision not to proceed with that proposal we will be focussing on implementing our plans to deliver value for Interserve shareholders through the medium term growth of our business, as outlined in our recent annual results presentation."

Enquiries:

Interserve

Tel: +44 (0)118 932 0123Adrian Ringrose (Chief Executive)Tim Haywood (Group Finance Director)J.P. Morgan Cazenove (Financial adviser & joint broker to Interserve)Tel: +44 (0)20 7588 2828Patrick MageeNiklas KloepferOriel Securities Limited (Joint broker to Interserve)Tel: +44 (0)20 7710 7600Emma GriffinMichael ShawMaitland (PR adviser to Interserve)Tel: +44 (0)20 7379 5151Neil BennettElizabeth Morley

This announcement will be available on Interserve's website (www.interserve.com) by no later than 12 noon (London time) on 30 March 2011.

This announcement is made in accordance with Rule 2.8 of the City Code on Takeovers and Mergers (the "Code").

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities. This announcement has been prepared in accordance with English law and the Takeover Code and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside of the United Kingdom.

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

J.P. Morgan plc, which conducts its UK investment banking business as J.P. Morgan Cazenove and is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Interserve and for no one else in connection with this announcement, and will not be responsible to anyone other than Interserve for providing the protections afforded to clients of J.P. Morgan plc nor for providing advice in connection with this announcement or any matter referred to herein.

Oriel Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Interserve and for no one else in connection with this announcement, and will not be responsible to anyone other than Interserve for providing the protections afforded to clients of Oriel Securities Limited nor for providing advice in connection with this announcement or any matter referred to herein.

Forward looking statements

This announcement contains statements about Interserve and Mouchel that are or may be forward looking statements. All statements other than statements of historical facts included in this announcement may be forward looking statements. Without limitation, any statements preceded or followed by or that include the words "targets", "plans" "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or words or terms of similar substance or the negative thereof, are forward looking statements. Forward looking statements include statements relating to, among other things, the expected benefits of the proposed combination of Interserve and Mouchel.

Such forward looking statements involve risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward looking statements, including, among others, risks relating to the successful combination of Mouchel with Interserve; higher than anticipated costs relating to the combination of Mouchel with Interserve; and facts relating to Mouchel that may impact the timing or amount of benefit realised from the combination that are unknown to Interserve. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward looking statements, which speak only as of the date hereof. Interserve disclaims any obligation to update any forward looking or other statements contained herein, except as required by applicable law.

vendor
Date   Source Headline
15th Mar 20196:27 pmRNSInterserve
15th Mar 20195:56 pmRNSSuccessful completion of sale of the Group
15th Mar 20192:47 pmRNSHolding(s) in Company
15th Mar 20192:01 pmRNSParent Company Administration
15th Mar 201912:33 pmRNSResult of General Meeting
14th Mar 201911:41 amRNSTotal Voting Rights and Warrant Update
14th Mar 20199:18 amRNSDirector/PDMR Shareholding
12th Mar 20198:30 amRNSBlock Listing Application
11th Mar 20195:27 pmRNSResponse to media reports re Deleveraging Plan
5th Mar 201912:56 pmRNSResponse to proposal Coltrane Asset Management L.P
4th Mar 20196:03 pmRNSUpdate on Coltrane Asset Management L.P Proposal
28th Feb 20199:58 amRNSPublication of a Prospectus
27th Feb 20199:05 amRNSDeleveraging Plan details and launch
27th Feb 20198:58 amRNSFull Year Results 2018
26th Feb 20194:17 pmRNSNotice of Requisition General Meeting
22nd Feb 20193:54 pmRNSHolding(s) in Company
22nd Feb 20193:50 pmRNSUpdate on Deleveraging Plan
20th Feb 20199:56 amRNSHolding(s) in Company
19th Feb 201910:13 amRNSHolding(s) in Company
13th Feb 20194:25 pmRNSDirector/PDMR Shareholding
12th Feb 20197:00 amRNSDirectorate Change
6th Feb 20197:10 amRNSStatement re Shareholder Requisition
6th Feb 20197:00 amRNSStatement re Deleveraging Plan
24th Jan 201912:07 pmRNSSecond Price Monitoring Extn
24th Jan 201912:02 pmRNSPrice Monitoring Extension
16th Jan 20191:14 pmRNSDirector/PDMR Shareholding
14th Jan 20194:41 pmRNSSecond Price Monitoring Extn
14th Jan 20194:36 pmRNSPrice Monitoring Extension
2nd Jan 201912:30 pmRNSHolding(s) in Company
2nd Jan 20197:00 amRNSBlock listing Interim Review
28th Dec 20184:20 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSProgress on Deleveraging Plan
17th Dec 20182:52 pmRNSDirector/PDMR Shareholding
10th Dec 20189:30 amRNSInterserve Awarded £25m Contract.
10th Dec 20187:00 amRNSDELEVERAGING PLAN
29th Nov 20182:30 pmRNSHolding(s) in Company
28th Nov 201810:50 amRNSHolding(s) in Company
27th Nov 20183:59 pmRNSHolding(s) in Company
23rd Nov 20182:07 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNS3rd Quarter Update
16th Nov 20184:12 pmRNSHolding(s) in Company
16th Nov 20184:09 pmRNSHolding(s) in Company
13th Nov 20182:50 pmRNSStatement following recent press coverage
13th Nov 201811:00 amRNSDirector/PDMR Shareholding
23rd Oct 201811:03 amRNSHolding(s) in Company
22nd Oct 20184:27 pmRNSHolding(s) in Company
17th Oct 20189:04 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSSALE OF ACCESS AND HARD SERVICES BUSINESS
1st Oct 20189:27 amRNSHolding(s) in Company
14th Sep 20189:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.